SCHEMBL1302607

SCHEMBL1302607

Cn1c(-c2ccccn2)nc(-c2ccc(C#N)nc2)c1Sc1ccc(Cl)cc1

nearest known ligand 0.70

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FAAH O00519 1/20 0.70
GRM5 P41594 4/20 0.41
L3MBTL1 Q9Y468 5/20 0.40
GAA P10253 2/20 0.39
LMNA P02545 2/20 0.39
POLB P06746 1/20 0.39
PPP1CA P62136 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
ALDH1A1 P00352 3/20 0.37
CYP1A2 P05177 3/20 0.37
CYP2C9 P11712 3/20 0.37
CYP2C19 P33261 3/20 0.37
KDM4E B2RXH2 3/20 0.37
TDP1 Q9NUW8 3/20 0.37
CYP3A4 P08684 2/20 0.37
HPGD P15428 2/20 0.37
CYP2D6 P10635 1/20 0.37
TSHR P16473 1/20 0.35
DCTPP1 Q9H773 1/20 0.34
CHEK1 O14757 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1304298 0.88 FAAH (0.67) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL7993064 0.87 FAAH (0.76) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL8005184 0.84 FAAH (0.61) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL1429881 0.83 FAAH (0.72) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL8008516 0.83 FAAH (0.71) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL1302339 0.83 FAAH (0.60) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL8006312 0.83 FAAH (1.00) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL1304088 0.82 FAAH (0.69) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL1302433 0.82 FAAH (0.72) FAAHGRM5L3MBTL1GAALMNA
SCHEMBL1303678 0.82 FAAH (0.69) FAAHGRM5L3MBTL1GAALMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US claimed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US claimed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-8455528-B2 Imidazole derivatives useful as inhibitors of FAAH MERCK SHARP & DOHME CORP. (US) 2013-06-04 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK SHARP & DOHME CORP. 2011-11-03 US disclosed
WO-2009152025-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH MERCK & CO., INC. (US) 2009-12-17 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110269769-A1 IMIDAZOLE DERIVATIVES USEFUL AS INHIBITORS OF FAAH FAAH, FAAH2, HNMT FAAH 1/4885GRM5 786/4885L3MBTL1 4341/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.